- Home
- FENC vs NUS Comparison
FENC vs NUS Comparison
Compare FENC & NUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FENC | NUS |
|---|---|---|
| Founded | 1996 | 1984 |
| Country | United States | United States |
| Employees | N/A | 8600 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Other Pharmaceuticals |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 230.8M | 266.5M |
| IPO Year | 2010 | 1996 |
Fundamental Metrics
Financial Performance| Metric | FENC | NUS |
|---|---|---|
| Price | $11.57 | $5.46 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $14.50 | N/A |
| AVG Volume (30 Days) | 127.4K | ★ 507.8K |
| Earning Date | 05-12-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 3.36% |
| EPS Growth | N/A | ★ 207.80 |
| EPS | 0.01 | ★ 0.04 |
| Revenue | $44,642,000.00 | ★ $3,176,718,000.00 |
| Revenue This Year | $65.12 | N/A |
| Revenue Next Year | $41.08 | $7.14 |
| P/E Ratio | $1,084.00 | ★ $129.75 |
| Revenue Growth | N/A | ★ 48.98 |
| 52 Week Low | $5.65 | $4.89 |
| 52 Week High | $11.31 | $14.62 |
Technical Indicators
Market Signals| Indicator | FENC | NUS |
|---|---|---|
| Relative Strength Index (RSI) | 60.06 | 47.59 |
| Support Level | $9.91 | $4.95 |
| Resistance Level | $11.28 | $5.43 |
| Average True Range (ATR) | 0.60 | 0.16 |
| MACD | 0.02 | 0.02 |
| Stochastic Oscillator | 92.92 | 42.86 |
Price Performance
Historical ComparisonAbout FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.
About NUS Nu Skin Enterprises Inc.
Nu Skin Enterprises Inc develops and distributes a comprehensive line of beauty and wellness solutions in various countries. The company operates in two primary product categories: beauty and wellness products. Additionally, the company also operates through its subsidiary, Rhyz. It reports revenue from nine segments, consisting of its seven geographic Nu Skin segments: Americas, Southeast Asia/Pacific, Mainland China, Japan, Europe & Africa, South Korea, and Hong Kong/Taiwan and two Rhyz segments: manufacturing, which includes manufacturing and packaging subsidiaries it has acquired; and Rhyz Other, which includes other investments by its Rhyz strategic investment arm. The majority of the company's revenue is generated from the Wellness product category from the Americas segment.